Printer Friendly

Browse Vascular endothelial growth factor topic

Articles

1-300 out of 410 article(s) nextnext page
Title Author Type Date Words
Iconic Therapeutics Begins Second Phase 2 Study of Icon-1 in Patients With Neovascular AMD. May 22, 2018 267
Quotation For Consumables & Chemicals For Department Of General Surgery. May 18, 2018 107
KalVista presents data in support of DME development activities at ARVO. May 2, 2018 195
Ophthotech completes patient recruitment in Phase 2a Zimura combination trial. May 1, 2018 159
Adverum announces long-term preclinical efficacy data on ADVM-022 gene therapy. May 1, 2018 220
ThromboGenics begins Phase 2 study of anti-PlGF in combination with anti-VEGF for DME. Apr 27, 2018 244
ThromboGenics begins Phase 2 study of anti-PlGF in combination with anti-VEGF for DME. Apr 27, 2018 240
Kodiak Sciences closes USD33m mezzanine private financing. Apr 27, 2018 133
Kodiak Sciences closes USD33m mezzanine private financing. Apr 27, 2018 129
amcure Pre-Clinical Data on AMC303's Anti-tumor and Anti-Metastatic Effects Presented at AACR. Apr 20, 2018 280
Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials. Karakiewicz, Pierre I.; Zaffuto, Emanuele; Kapoor, Anil; Basappa, Naveen S.; Bjarnason, Georg A.; Bl Report Apr 6, 2018 4565
Eli Lilly liver cancer drug meets primary endpoints in phase three Reach-two study. Apr 6, 2018 249
Eli Lilly liver cancer drug meets primary endpoints in phase three Reach-two study. Apr 6, 2018 245
ThromboGenics reveals initial data from THR-317 study. Apr 4, 2018 181
ThromboGenics reveals initial data from THR-317 study. Apr 4, 2018 177
Effects of Neonicotinoid Pesticides on Promoter-Specific Aromatase (CYP19) Expression in Hs578t Breast Cancer Cells and the Role of the VEGF Pathway. Caron-Beaudoin, Elyse; Viau, Rachel; Sanderson, J. Thomas Apr 1, 2018 9559
THE EFFECT OF MODERATE EXERCISE ON VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION DURING TOOTH SOCKET WOUND HEALING AFTER TOOTH EXTRACTION. Report Mar 31, 2018 2410
Eisai and Merck to collaborate on anticancer agent lenvima. Mar 9, 2018 349
Eisai and Merck to collaborate on anticancer agent lenvima. Mar 9, 2018 345
Clearside Biomedical announces enrollment of first patient in TOPAZ trial. Mar 6, 2018 299
Neuroprotective Effects of Ganoderma lucidum on Spinal Cord Injury/Efectos Neuroprotectores de Ganoderma lucidum en la Lesion de la Medula Espinal l. Aysun, Ekinci; Huseyin, Ozevren; Emre, Bilgic Bulent; Cenap, Ekinci; Senay, Deveci; Engin, Deveci Mar 1, 2018 3190
Hutchison China MediTech completes patient enrollment in Phase III FALUCA trial. Feb 13, 2018 134
Effects of bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) release from polylactide-poly (ethylene glycol)-polylactide (PELA) microcapsule-based scaffolds on bone. Ren, Q.; Cai, M.; Zhang, K.; Ren, W.; Su, Z.; Yang, T.; Sun, T.; Wang, J. Report Feb 1, 2018 3298
Mechanism of hif-1 [alpha] mediated hypoxia-induced permeability changes in bladder endothelial cells. Liu, C.; Shui, C.L.; Wang, Q.; Luo, H.; Gu, C.G. Report Feb 1, 2018 3524
PHARMABCINE COLLABORATES WITH MSD ON CLINICAL EVAL. Feb 1, 2018 677
Clinical Data from Taiho Oncology and Servier Study of Lonsurf (trifluridine and tipiracil) in Metastatic Colorectal Cancer Presented at ASCO 2018 Gastrointestinal Cancers Symposium. Jan 24, 2018 436
Aveo Oncology Presents Results of Phase 1b/2 Study of Tivozanib in Patients with Advanced Hepatocellular Carcinoma. Jan 23, 2018 430
Amgen & Allergan's MVASI (Biosimilar Bevacizumab) approved by EC for certain types of cancer. Jan 19, 2018 300
Amgen & Allergan's MVASI (Biosimilar Bevacizumab) approved by EC for certain types of cancer. Jan 19, 2018 296
AVEO says tivozanib study results show 'favorable' response rate, safety profile. Jan 19, 2018 222
United Kingdom,United States : Momenta and Mylan Announce Development Strategy for M710, a Proposed Biosimilar to EYLEA (aflibercept). Jan 4, 2018 251
Status of inflammatory markers and growth factor in gastric ulcer protective effects of Punica granatum L. peel extract in rat. Chauhan, Indal; Agrawal, Sudhanshu; Goel, Raj Kumar Report Jan 1, 2018 4356
Effects of Hypoxic Training versus Normoxic Training on Exercise Performance in Competitive Swimmers. Park, Hun-Young; Lim, Kiwon Report Dec 1, 2017 7519
CLINICAL SIGNIFICANCE OF VEGF-A AND MICROVESSEL DENSITY IN DIFFUSE LARGE B-CELL LYMPHOMA AND LOW-GRADE FOLLICULAR LYMPHOMA. Shahini, Labinot; Gasparov, Slavko; Petrusevska, Gordana; Kerliu, Suzana Manxhuka; Veselaj, Fahredin Report Dec 1, 2017 3480
Safflower Extract and Aceglutamide Injection Promoting Recovery of Peripheral Innervations via Vascular Endothelial Growth Factor-B Signaling in Diabetic Mice. Li, Dan; Chen, You-Gang; Zhang, Cui-Juan; Tian, Jing; Li, Xia Dec 1, 2017 4524
Management of neovascular AMD in secondary care. Fulcher, Corinne Dec 1, 2017 3173
Regeneron Pharmaceuticals' Phase two studies of eye-drug combination fail to warrant phase three development. Nov 29, 2017 232
Regeneron Pharmaceuticals' Phase two studies of eye-drug combination fail to warrant phase three development. Nov 29, 2017 228
Notal Vision Collaborates with IRIS Registry to Improve Understanding of Visual Acuity in AMD. Nov 13, 2017 276
Case: Secondary polycythemia due to pazopanib in patients with metastatic renal cell carcinoma. Bukhari, Nedal Report Nov 1, 2017 1532
The Efficacy and Safety of Intravitreal Dexamethasone Implant for the Treatment of Macular Edema Related to Retinal Vein Occlusion: Real-life Data and Prognostic Factors in a Turkish Population. Kanra, Ayge Yagmur; Akcakaya, Aylin Ardagil; Yaylali, Sevil Ari; Altinel, Meltem Giizin; Sevimli, Ne Report Nov 1, 2017 4830
Hutchison China MediTech initiates FRUTIGA Phase III clinical trial of fruquintinib. Oct 31, 2017 220
Hutchison China MediTech initiates FRUTIGA Phase III clinical trial of fruquintinib. Oct 31, 2017 216
X4 Pharmaceuticals Completes Dose Escalation Portion of Clinical Trial of X4P-001-IO in Combination with Inlyta (Axitinib) in Patients with Clear Cell Renal Cell Carcinoma. Oct 31, 2017 348
Chi-Med reveals preliminary Phase II data for fruquintinib combination. Oct 16, 2017 187
Content of markers of respiratory tract remodeling in exhaled breath condensate in children suffering from bronchial asthma. Koloskova, Olena; Bilous, Tetiana; Bilyk, Galyna; Lobanova, Tetiana; Dikal, Mariana; Bilous, Volodym Sep 1, 2017 2596
Endocan Measurement for Active Behcet Disease. Kul, Ayhan; Ates, Orhan; Melikoglu, Meltem Alkan; Ugur, Mahir; Ozturk, Nurinnisa; Erkayhan, Gulsum; Sep 1, 2017 3243
X4 Pharmaceuticals to Present Data from Study of X4P-001-IO and Inlyta (axitinib) Combination at European Society of Medical Oncology 2017 Congress. Sep 1, 2017 242
Germany : Bayer to showcase latest Ophthalmology research at EURETINA 2017. Sep 1, 2017 661
Outcomes of Intravitreal Dexamethasone Implant in the Treatment of Recalcitrant Diabetic Macular Edema. Akincioglu, Dorukcan; Kucukevcilioglu, Murat; Durukan, Ali Hakan; Aykaws, Seckin; Ayyildiz, Onder; E Report Sep 1, 2017 3091
Development of VEGF-loaded PLGA matrices in association with mesenchymal stem cells for tissue engineering. Rosa, A.R.; Steffens, D.; Santi, B.; Quintiliano, K.; Steffen, N.; Pilger, D.A.; Pranke, P. Sep 1, 2017 7845
RETINAL NERVE FIBER LAYER THICKNESS IN GLAUCOMA PATIENTS TREATED WITH MULTIPLE INTRAVITREAL ANTL-VEGF (BEVACIZUMAB) INJECTIONS. Kopic, Andrijana; Biuk, Dubravka; Barac, Josip; Vinkovic, Maja; Benasic, Tvrtka; Kopic, Vlatko Report Sep 1, 2017 4633
AVEO Oncology's Fotivda (tivozanib) Approved in the European Union, Norway, and Iceland for Treatment of Advanced Renal Cell Carcinoma. Aug 29, 2017 330
Ophthotech fails to meet primary endpoint in phase three Fovista trial. Aug 15, 2017 197
Ophthotech fails to meet primary endpoint in phase three Fovista trial. Aug 15, 2017 193
Allegro Ophthalmics' Luminate integrin peptide therapy passes phase two trial. Aug 11, 2017 235
Allegro Ophthalmics DEL MAR Study of Luminate as Sequential Therapy in Patients with Diabetic Macular Edema Meets Primary Endpoint. Aug 10, 2017 387
Vitreoretinal cases. McArthur, Craig Aug 1, 2017 552
Transforming Growth Factor-beta 1 Involved in the Pathogenesis of Endometriosis through Regulating Expression of Vascular Endothelial Growth Factor under Hypoxia. Yu, Yue-Xin; Xiu, Yin-Ling; Chen, Xi; Li, Ya-Li Report Jul 27, 2017 5843
Internal Medicine. Jul 1, 2017 262
Elevated Levels of Serum Vascular Endothelial Growth Factor-A Are Not Related to NK Cell Parameters in Recurrent IVF Failure. Bansal, Rhea; Ford, Brian; Bhaskaran, Shree; Thum, Meenyau; Bansal, Amolak Report Jul 1, 2017 5006
Undiagnosed mental illness in wet AMD patients. Powell, Selina Clinical report Jun 1, 2017 218
Angiogenesis and Tumor Progression Inhibition of Cyclooxygenase-2 Selective Inhibitor Celecoxib Associated with Poly (lactic-co-glycolic acid) in Tumor Cell Line Resistant to Chemotherapy/Inhibicion de Angiogenesis y Progresion Tumoral por Inhibidor Selectivo de Ciclooxigenasa-2 Celecoxib Asociado con Acido (poli lactico co-glicolico) en Linea de Celulas Tumorales Resistentes a Quimioterapia. Roa, Ignacio; Cantin, Mario; Vilos, Cristian; Rosas, Carlos; Lemus, David Jun 1, 2017 4380
Effects of siRNA-mediated HIF-1a gene silencing on angiogenesis in osteosarcoma. Apr 30, 2017 2101
Histologic correlation of VEGF and COX-2 expression with tumor size in squamous cell carcinoma of the larynx and hypopharynx. Bonhin, Rodrigo Gonzalez; de Carvalho, Guilherme Machado; Guimaraes, Alexandre Caixeta; Rocha, Vanes Report Apr 1, 2017 2631
O24: Interrogating the role of angiogenesis genes on musculoskeletal soft tissue injury risk. Rahim, M.; Saunders, C.J.; Gibbon, A.; Ly, Khoury El; Raleigh, S.M.; Ribbans, W.J.; Posthumus, M.; G Report Mar 22, 2017 109
Yrogenex Completes Patient Enrollment in Phase 2 Trial of Orally Administered Vorolanib. Clinical report Mar 13, 2017 254
Diabetic macular edema: Traditional and novel treatment. Tomic, Martina; Vrabec, Romano; Poljicanin, Tamara; Ljubic, Spomenka; Duvnjak, Lea Report Mar 1, 2017 6279
Study on the effect of chemoembolization combined with microwave ablation for the treatment of hepatocellular carcinoma in rats. Vogl, Thomas Josef; Qian, Jun; Tran, Andreas; Oppermann, Elsie; Naguib, Nagy N.; Korkusuz, Huedayi; Mar 1, 2017 4002
Kaempferol inhibited VEGF and PGF expression and in vitro angiogenesis of HRECs under diabetic-like environment. Xu, X.H.; Zhao, C.; Peng, Q.; Xie, P.; Liu, Q.H. Report Mar 1, 2017 4068
Exelixis & Takeda partnership to commercialise and develop novel cancer therapy cabozantinib in Japan. Jan 31, 2017 313
Exelixis & Takeda partnership to commercialise and develop novel cancer therapy cabozantinib in Japan. Jan 31, 2017 309
Topical binahong (Anredera cordifolia) leaf extract increases Interleukin-6 and VEGF (vascular endothelial growth factor) during burn wound healing in wistar rats infected with Pseudomonas aeruginosa. Sukrama, Dewa Made; Wihandani, Desak Made; Manuaba, Amertha Putra Report Jan 1, 2017 4139
Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 in Cancer Development and Tumor Angiogenesis. Corlan, Ana Silvia; Cimpean, Anca Maria; Jitariu, Adriana-Andreea; Melnic, Eugen; Raica, Marius Jan 1, 2017 10315
Comparative Effectiveness of Bone Grafting Using Xenograft Freeze-Dried Cortical Bovine, Allograft Freeze-Dried Cortical New Zealand White Rabbit, Xenograft Hydroxyapatite Bovine, and Xenograft Demineralized Bone Matrix Bovine in Bone Defect of Femoral Diaphysis of White Rabbit: Experimental Study In Vivo. Mahyudin, Ferdiansyah; Utomo, Dwikora Novembri; Suroto, Heri; Martanto, Tri Wahyu; Edward, Mouli; Ga Report Jan 1, 2017 3750
Correlation of Vascular Endothelial Growth Factor Production with Photochemical Reaction-induced Retinal Edema. Shan, Liang; Zheng, Mi; Zhang, Yuan; Qu, Yuan; Niu, Tian; Gu, Qing; Liu, Kun; Xia, Xin Report Dec 20, 2016 4192
Ophthotech reports disappointing results from Pivotal Phase 3 trials of Fovista in wet age macular degeneration patients. Clinical report Dec 12, 2016 328
Ophthotech reports disappointing results from Pivotal Phase 3 trials of Fovista in wet age macular degeneration patients. Clinical report Dec 12, 2016 324
Amgen and Allergan submit Marketing Authorisation Application to European Medicines Agency for ABP 215. Dec 6, 2016 170
Amgen and Allergan submit Marketing Authorisation Application to European Medicines Agency for ABP 215. Dec 6, 2016 166
Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity. Li, Xiu-Juan; Yang, Xiao-Peng; Sun, Shuang; Lyu, Xiao-Bei; Jia, Heng Report Dec 5, 2016 1608
Sindrome PAGOD y anomalias vasculares: ?es un defecto de la angiogenesis embrionaria? Un nuevo caso y revision. Delgado-Luengo, Wilmer; Jeitas-Cabello, Herminia F.; Solis-Anez, Ernesto; Hernandez-Rodriguez, Maria Dec 1, 2016 5630
United States : Athenex, Lilly partner in phase 1b study of oraxol. Nov 21, 2016 210
MicroRNA-210 Plays a Critical Role in the Angiogenic Effect of Isoprenaline on Human Umbilical Vein Endothelial Cells via Regulation of Noncoding RNAs. Yan, You-You; Wang, Zhi-Hui; Zhao, Lei; Song, Dan-Dan; Qi, Chao; Liu, Lu-Lu; Wang, Jun-Nan Nov 20, 2016 4002
United States : Athenex and Lilly Enter Clinical Collaboration Agreement. Nov 19, 2016 298
amcure announces initiation and first patient treated in a Phase I/Ib clinical study of AMC303 for cancer treatment. Clinical report Oct 27, 2016 314
amcure announces initiation and first patient treated in a Phase I/Ib clinical study of AMC303 for cancer treatment. Clinical report Oct 27, 2016 310
US FDA Clears Genentech's Lucentis (Ranibizumab Injection) Prefilled Syringe. Oct 18, 2016 624
United States : FDA Approves Genentechs Lucentis (Ranibizumab Injection) Prefilled Syringe. Oct 15, 2016 247
Current concepts in the pathogenesis and management of vascular lesions--a brief review. Sarangi, Snehanjan; Mukherjee, Debanjali Report Oct 1, 2016 3614
Japan,United Kingdom : Eisai receives license for new indication for anticancer agent Kisplyx(LENVATINIB MESYLATE) for treatment of advanced renal cell. Sep 19, 2016 549
Eisai Receives License for New Indication for Anticancer Agent Kisplyx (Lenvatinib Mesylate) for Treatment of Advanced Renal Cell Carcinoma. Clinical report Sep 15, 2016 1466
Procurement Of Aflibercept And Ranibizumab ( Anti-vegf ) On The Requisition In 2017 , Sll450 , The Stockholm County Council And Region Gotland . Sep 14, 2016 128
Effects of Xylene on Respiratory Mucosa in Rats/ Efectos del Xileno sobre la Mucosa Respiratoria de Ratas. Eda, Arslan; Baver, Samanci; Seyla, Samanci Bolukbasi; Huseyin, Ozevren; Deveci, E. Sep 1, 2016 1885
Vascular Endothelial Growth Factor and Cluster of Differentiation 34 for Assessment of Perioperative Bleeding Risk in Gastric Cancer Patients. He, Mu-Qing; He, Mu-Qun; Wang, Jian-Feng; Zhu, Bao-Ling; Sun, Ni; Zhou, Xiao-Hai; Yao, Rong-Xin Report Aug 20, 2016 2808
Blood levels of pro-inflammatory and anti-inflammatory cytokines during an oral glucose tolerance test in patients with symptoms suggesting reactive hypoglycemia. Filho, W. Eik; Marcon, S.S.; Krupek, T.; Previdelli, I.T.S.; Pereira, O.C.N.; Silva, M.A.R.C.P.; Baz Report Aug 1, 2016 4132
United Kingdom : AstraZeneca files first clinical trial application in Moderna messenger RNA collaboration. Jul 27, 2016 385
United Kingdom : Two new medicines for advanced kidney cancer. Jul 23, 2016 699
Eisai Receives Positive CHMP Opinion on New Indication for Anticancer Agent Lenvatinib in Combination with Everolimus for Treatment of Advanced Renal Cell Carcinoma. Jul 22, 2016 1275
STRONG: European Consortium for the Study of a Topical Treatment of iCRVO to prevent Neovascular Glaucoma. Jul 21, 2016 474
Visual acuity losses during ongoing anti-VEGF injections. Brief article Jul 1, 2016 286
Quercetin alleviates pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Li, X.; Chen, Y.; Wang, L.; Shang, G.; Zhang, C.; Zhao, Z.; Zhang, H.; Liu, A. Report Jul 1, 2016 5009
Germany: Role of Angiogenic Factors in Neurodevelopment. Jun 28, 2016 296
Mutated Gene Influencing Metastatic Colorectal Cancer Survival Rate, According to PiscoMed's Journal AMOR. Jun 3, 2016 822
Three cures in one. Brief article Jun 1, 2016 116
Japan : Anti-Cancer Agent Avastin, Obtained Approval for Additional Indication of Advanced or Recurrent Cervical Cancer. May 24, 2016 290
Austria : Evercyte GmbH, VTU Technology partner to develop recombinant media supplements. May 24, 2016 290
Pluristem to acquire rights for placental cell therapy patent. May 2, 2016 371
Pluristem to acquire rights for placental cell therapy patent. May 2, 2016 371
Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy. Song, Yan; Du, Chun-Xia; Zhang, Wen; Sun, Yong-Kun; Yang, Lin; Cui, Cheng-Xu; Chi, Yihe-Bali; Shou, Report May 1, 2016 3152
Promoting inflammatory lymphangiogenesis by vascular endothelial growth factor-C (VEGF-C) aggravated intestinal inflammation in mice with experimental acute colitis. Wang, X.L.; Zhao, J.; Qin, L.; Qiao, M. Report May 1, 2016 6618
Impacts of N-Butylphthalide on expression of growth factors in rats with focal cerebral ischemia. Jiang, Yan; Sun, Leyu; Xuan, Xiaoyan; Wang, Jianping May 1, 2016 3711
Taiho Pharmaceutical receives marketing authorisation for Lonsurf from European Commission. Apr 29, 2016 168
Taiho Pharmaceutical receives marketing authorisation for Lonsurf from European Commission. Apr 29, 2016 164
Germany,United States : Merck and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA in Renal Cell Carcinoma. Apr 7, 2016 498
Germany,United States : Merck and Pfizer announce first Patient treated in Phase III Combination Study with Avelumab and INLYTA in Renal Cell Carcinom. Apr 6, 2016 546
Regeneron and Bayer partnership to develop novel combination therapy for eye diseases. Mar 25, 2016 227
Regeneron and Bayer partnership to develop novel combination therapy for eye diseases. Mar 25, 2016 223
Germany,United States : Bayer and Regeneron To Jointly Develop Novel Combination Therapy for Eye Diseases. Mar 25, 2016 443
Nerve Growth Factor Promotes Angiogenesis and Skeletal Muscle Fiber Remodeling in a Murine Model of Hindlimb Ischemia. Diao, Yong-Peng; Cui, Feng-Kui; Yan, Sheng; Chen, Zuo-Guan; Lian, Li-Shan; Guo, Li-Long; Li, Yong-Ju Report Mar 1, 2016 4104
Investigation of Various Events Occurring in the Brain Tissue After Calvarial Defects in Rats/Investigacion de las Alteraciones Ocurridas en el Tejido Cerebral Posterior a la Creacion de Defectos en la Calvaria de Ratas. Tas, Mahmut; Gok, Ertugrul; Ekinci, Cenap; Deveci, Engin; Deveci, Senay Mar 1, 2016 2720
Pravastatin induces cell cycle arrest and decreased production of VEGF and bFGF in multiple myeloma cell line/Pravastatina induz parada no ciclo celular e diminuicao na producao de VEGF e bFGF em linhagem de Mieloma Multiplo. Trojan, P.J.J.; Bohatch, M.S., Jr.; Otuki, M.F.; Souza-Fomeca-Guimaraes, F.; Svidnicki, P.V.; Nogaro Feb 1, 2016 3467
Preclinical Alzheimer's disease data published. Jan 18, 2016 249
Alzheimer's disease data published. Jan 11, 2016 245
Alzheimer's disease data published. Jan 11, 2016 245
Alterations of Thymic Epithelial Cells in Lipopolysaccharide-induced Neonatal Thymus Involution. Zhou, Yong-Jie; Peng, Hua; Chen, Yan; Liu, Ya-Lan Report Jan 1, 2016 3876
Cloning and optimization of soluble vascular endothelial growth [Factor.sub.165] expression in Escherichia coli. Salimi, Ali; Babashamsi, Mohammad Report Jan 1, 2016 3896
The Favorable Effect of Mesenchymal Stem Cell Treatment on the Antioxidant Protective Mechanism in the Corneal Epithelium and Renewal of Corneal Optical Properties Changed after Alkali Burns. Cejka, Cestmir; Holan, Vladimir; Trosan, Peter; Zajicova, Alena; Javorkova, Eliska; Cejkova, Jitka Jan 1, 2016 6265
Treatment outcomes in patients with polypoidal choroidal vasculopathy. Muslubas, Isil Sayman; Hocaoglu, Mumin; Arf, Serra; Ozdemir, Hakan; Karacorlu, Murat Report Jan 1, 2016 2907
Detection of autoantibodies to vascular endothelial growth factor receptor-3 in bile duct ligated rats and correlations with a panel of traditional markers of liver diseases. Duval, Florent; Cruz-Vega, Delia Elva; Gonzalez-Gamboa, Ivonne; Gonzalez-Garza, Maria Teresa; Ponz, Jan 1, 2016 5594
miR-1 inhibits cell growth, migration, and invasion by targeting VEGFA in osteosarcoma cells. Niu, Junjie; Sun, Yibao; Guo, Qiaoge; Niu, Dongju; Liu, Bo Report Jan 1, 2016 4699
Immunohistochemical expression of VEGF and podoplanin in uterine cervical squamous intraepithelial lesions. Belfort-Mattos, Patricia Napoli; de Azevedo Focchi, Gustavo Rubino; Ribalta, Julisa Chamorro Lascasa Report Jan 1, 2016 4906
Effect of High-Intensity Training in Normobaric Hypoxia on Thoroughbred Skeletal Muscle. Nagahisa, Hiroshi; Mukai, Kazutaka; Ohmura, Hajime; Takahashi, Toshiyuki; Miyata, Hirofumi Jan 1, 2016 6230
Effect of Hyperbaric Oxygen on the Growth of Intracranial Glioma in Rats. Ding, Jian-Bo; Chen, Jun-Rui; Xu, Hong-Zhi; Qin, Zhi-Yong Report Dec 5, 2015 4621
Expression of Angiogenic Factors in Invasive Retinoblastoma Tumors Is Associated With Increase in Tumor Cells Expressing Stem Cell Marker Sox2. Garcia, Jesus R.; Gombos, Dan S.; Prospero, Claudia M.; Ganapathy, Aravindh; Penland, Rebecca L.; Ch Dec 1, 2015 5748
Biology of Vascular Development: Mechanisms in Physiological Conditions and Shear Stress/ Biologia del Desarrollo Vascular: Mecanismos en Condiciones Fisiologicas y Estres Flujo. Rodriguez-Nunez, Ivan; Romero, Fernando; Gonzalez, Marcelo; Campos, Ruy R. Dec 1, 2015 3885
Activation of endogenous angiotensin converting enzyme 2 prevents early injuries induced by hyperglycemia in rat retina. Foureaux, G.; Nogueira, B.S.; Coutinho, D.C.O.; Raizada, M.K.; Nogueira, J.C.; Ferreira, A.J. Report Dec 1, 2015 4041
Regeneron passes EU approval for EYLEA Injection for the treatment of myopic CNV. Nov 2, 2015 232
Regeneron passes EU approval for EYLEA Injection for the treatment of myopic CNV. Nov 2, 2015 228
Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF [sub]165 b Isoform in the Vitreous of Patients with Retinopathy of Prematurity. Zhao, Min; Xie, Wan-Kun; Bai, Yu-Jing; Huang, Lyu-Zhen; Wang, Bin; Liang, Jian-Hong; Yin, Hong; Li, Report Sep 20, 2015 3331
Evaluation of vascular endothelial growth factors A, C and D as indicators of lymphangiogenesis and angiogenesis in invasive and non-invasive urothelial carcinoma bladder. Aug 31, 2015 3821
Macular degeneration: emerging treatments and a changing research landscape. O'Hare, Ryan Brief article Aug 8, 2015 314
Real-world anti-VEGF results: Br J Ophthalmol (bit.ly/IIslZSU). O'Hare, Ryan Brief article Aug 8, 2015 283
Analyses of Potential Predictive Markers and Response to Targeted Therapy in Patients with Advanced Clear-cell Renal Cell Carcinoma. Song, Yan; Huang, Jing; Shan, Ling; Zhang, Hong-Tu Report Aug 5, 2015 4317
Tongxinluo Inhibits Cyclooxygenase-2, Inducible Nitric Oxide Synthase, Hypoxia-inducible Factor-2a/Vascular Endothelial Growth Factor to Antagonize Injury in Hypoxia-stimulated Cardiac Microvascular Endothelial Cells. Li, Yan-Ning; Wang, Xiu-Juan; Li, Bin; Liu, Kun; Qi, Jin-Sheng; Liu, Bing-Hui; Tian, Ye Report Aug 1, 2015 3627
Metastatic renal cell cancer: summary from ASCO 2015. Conference notes Aug 1, 2015 2447
Therapeutic potential of mesenchymal stem cells in the treatment of gastric ulcer. Rashed, Laila; Fayez, Salwa Report Aug 1, 2015 3063
Rat visceral yolk sac cells: viability and expression of cell markers during maternal diabetes. Aires, M.B.; Santos, J.R.A.; Souza, K.S.; Farias, P.S.; Santos, A.C.V.; Fioretto, E.T.; Maria, D.A. Report Aug 1, 2015 4631
AMD_CNV_HIF: Investigating the role of HIFs in myeloid cells during experimental choroidal neovascularisation. Jun 9, 2015 260
Casi Pharmaceuticals files application with China's Food and Drug Administration for approval of ENMD-2076. Jun 8, 2015 185
Casi Pharmaceuticals files application with China's Food and Drug Administration for approval of ENMD-2076. Jun 8, 2015 181
RXi Pharmaceuticals awarded USPTO's Notice of Allowance for RXI-109 for use in the eye. Jun 4, 2015 196
RXi Pharmaceuticals awarded USPTO's Notice of Allowance for RXI-109 for use in the eye. Jun 4, 2015 192
Look to green tea and apples for health benefits. Jun 1, 2015 119
Lilly partners with AstraZeneca on immuno-oncology combination clinical trial in solid tumors. Jun 1, 2015 243
What's new in renal cell cancer research? Highlights of GU-ASCO 2015. Conference notes Jun 1, 2015 824
Expression of VEGF and CD68 in the Placenta of Gestational Diabetic Mothers (Immunohistochemistry and Ultrastructural Study)/ Expresion de VEGF y CD68 en la Placenta de Madres Diabeticas Gestacionales (Estudio Inmunohistoquimico y Ultraestructural). Yavuz, D.; Balsak, D.; Ekinci, C.; Tahaoglu, A.E.; Togrul, C.; Goruk, N.; Aktas, A.; Karaman, E. Report Jun 1, 2015 2091
Circulating endothelial cells are increased in chronic myeloid leukemia blast crisis. Godoy, C.R.T.; Levy, D.; Giampaoli, V.; Chamone, D.A.F.; Bydlowski, S.P.; Pereira, J. Jun 1, 2015 3683
"Global Diabetic Retinopathy Market 2015-2019 " is now available at Fast Market Research. May 25, 2015 557
TRACON wins US FDA's fast track designation for TRC105 for treating advanced renal cell carcinoma. May 15, 2015 222
TRACON wins US FDA's fast track designation for TRC105 for treating advanced renal cell carcinoma. May 15, 2015 218
HUTCHISON MEDIPHARMA RECEIVES US$18 MILLION IN PAYMENTS. May 1, 2015 904
Clinical significance of COX-2, GLUT-1 and VEGF expressions in endometrial cancer tissues. Apr 30, 2015 3366
Apoptosis and inflammation form the mystery of pathogenesis of diabetic retinopathy. Mondal, Lakshmi Kanta; Biswas, Debasis; Samaddar, Sandip; Bhaduri, Gautam; Choudhari, Subhadip Report Apr 2, 2015 3377
Sequential treatments in hereditary leiomyomatosis and renal cell carcinoma (HLRCC): case report and review of the literature. de Velasco, Guillermo; Munoz, Cesar; Sepulveda, Juan M.; Castellano, Daniel Case study Apr 1, 2015 2140
Eisai's UK subsidiary received positive opinion for Lenvima. Mar 31, 2015 150
Eisai's UK subsidiary received positive opinion for Lenvima. Mar 31, 2015 146
U.S. patents for matrix biomaterial. Mar 9, 2015 112
U.S. patents for matrix biomaterial. Mar 9, 2015 111
CorMatrix Cardiovascular Issued 12 Additional US Patents. Mar 5, 2015 235
Eisai's US subsidiary launches Lenvima in US. Mar 4, 2015 184
Eisai's US subsidiary launches Lenvima in US. Mar 4, 2015 180
Triphase Accelerator signs academic centre collaboration with Sunnybrook Research Institute. Mar 2, 2015 170
Triphase Accelerator signs academic centre collaboration with Sunnybrook Research Institute. Mar 2, 2015 166
Diagnostic Values of Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptor for Benign and Malignant Hydrothorax. Gu, Yan; Zhang, Min; Li, Guo-Hua; Gao, Jun-Zhen; Guo, Liping; Qiao, Xiao-Juan; Wang, Li-Hong; He, La Report Mar 1, 2015 3349
The Effects of Polymeric Zinc Propylen-Bis-Dithiocarbamate (Propineb) on Tooth Development in Rats/Efectos del Propileno-Bis-Ditiocarbamato de Zinc Polimerico (Propineb) sobre el Desarrollo de los Dientes en Ratas. Mahmut, Koparal; Faruk, Er; Engin, Deveci; Dilek, Yavuz Medical condition overview Mar 1, 2015 1932
Genentech receives approval from US Food and Drug Administration for Lucentis. Feb 10, 2015 137
Genentech receives approval from US Food and Drug Administration for Lucentis. Feb 10, 2015 133
Eisai's Phase II Trial of Anticancer Agent Lenvatinib in Renal Cell Carcinoma Meets Primary Endpoint. Feb 2, 2015 1098
Expression patterns of VEGF and Flk-1 in human endometrium during the menstrual cycle. Lai, Tsung-Hsuan; Vlahos, Nikos; Shih, Ie-Ming; Zhao, Yulian Report Jan 1, 2015 3907
Association between the functional polymorphism of vascular endothelial growth factor gene and breast cancer: a meta-analysis. Li, Juan; Ju, Yongjian Report Jan 1, 2015 6792
Market Report, "Physician Views: Biosimilar Lucentis - what opportunity?", published. Dec 14, 2014 405
Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranib. Richter, Suzanne; Seah, Jo-An; Pond, Gregory R.; Gan, Hui K.; Mackenzie, Mary J.; Hotte, Sebastien J Report Dec 1, 2014 3357
DNA methylation regulates expression of VEGF-C, and S-adenosylmethionine is effective for VEGF-C methylation and for inhibiting cancer growth. Da, M.X.; Zhang, Y.B.; Yao, J.B.; Duan, Y.X. Report Dec 1, 2014 4706
ALTANGIOTARGET: Understanding tumour resistance: Receptors and signalling pathways that can lead the race against tumour angiogenesis. Nov 13, 2014 328
Blood vessel protein could help treat prostate tumours: Study. Nov 12, 2014 218
OncoMed gets US patent for anti-DLL4/anti-VEGF bispecific antibody. Nov 4, 2014 259
OncoMed Pharmaceuticals wins anti-DLL4/Anti-VEGF bispecific antibody patent in the US. Nov 4, 2014 158
OncoMed Pharmaceuticals wins anti-DLL4/Anti-VEGF bispecific antibody patent in the US. Nov 4, 2014 154
Investigation of VEGF-C involvement in acquired metastatic properties of renal cell carcinoma following anti-angiogenesis treatments. Oct 31, 2014 317
Polymorphisms of vascular endothelial growth factor on prognosis in osteosarcoma patients. Clinical report Oct 31, 2014 3553
Choroidal neovascular membrane. Lanier, Kate Oct 17, 2014 2893
Medical discovery first step on path to new painkillers. Oct 3, 2014 152
New insights into VEGF-A alternative splicing: key regulatory switching in the pathological process. Dehghanian, Fariba; Hojati, Zohreh; Kay, Maryam Report Oct 1, 2014 3786
Bone marrow mesenchymal stem cells overexpressing human basic fibroblast growth factor increase vasculogenesis in ischemic rats. Zhang, J.C.; Zheng, G.F.; Wu, L.; Yang, L.Y. Ou; Li, W.X. Report Oct 1, 2014 5780
Choroidal neo-vascularization presentation in younger age group (pre-senile). Sep 30, 2014 1287
Ophthalmic drug updates. Brief article Sep 19, 2014 282
Regeneron Pharmaceuticals applies marketing authorisation application for EYLEA Injection for macular edema following BRVO in Japan. Sep 4, 2014 220
Regeneron Pharmaceuticals applies marketing authorisation application for EYLEA Injection for macular edema following BRVO in Japan. Sep 4, 2014 216
Recombinant goat VEGF164 increases hair growth by painting process on the skin of shaved mouse. Bao, Wenlei; Yin, Jianxin; Liang, Yan; Guo, Zhixin; Wang, Yanfeng; Liu, Dongjun; Wang, Xiao; Wang, Z Report Sep 1, 2014 3069
Altitude training at sea level and its impact on EPO and VEGF. Mikulski, Tomasz; Dabrowski, Jan; Krzywanski, Jaroslaw Report Sep 1, 2014 2710
Study shows calprotectin, hs-CRP are serum biomarkers for clinical response in PoC spondyloarthritis studies. Aug 19, 2014 204
Regeneron Pharmaceuticals wins EU approval to market EYLEA Injection for Diabetic Macular Edema. Aug 11, 2014 182
Regeneron Pharmaceuticals wins EU approval to market EYLEA Injection for Diabetic Macular Edema. Aug 11, 2014 186
Study shows VEGFR-3, CXCR4 are predictive biomarkers for FLO, FLP therapy in advanced oesophagogastric cancer. Jul 1, 2014 286
Vascular Endothelial Growth Factor expression in peripheral blood of patients with pregnancy induced hypertension syndrome and its clinical significance. Report Jun 30, 2014 2663
Polimorfismo en el gen del factor de crecimiento vascular endotelial (VEGF) y su asociacion con la preeclampsia. Pacheco-Romero, Jose; Huerta, Doris; Acosta, Oscar; Cabrera, Santiago; Vargas, Marlene Jun 22, 2014 3455
Gastroprotective effect of epoxy clerodane diterpene isolated from Tinospora cordifolia miers (guduchi) on indomethacin-induced gastric ulcer in rats. Antonisamy, Paulrayer; Dhanasekaran, Muniyappan; Ignacimuthu, Savarimuthu; Duraipandiyan, Veeramuthu Report Jun 15, 2014 2686
Cancer drug hope for eye diseases. Brief article Jun 6, 2014 106
Molecular characterization and expression analysis of equine vascular endothelial growth factor alpha (VEGF[alpha]) gene in horse (Equus caballus). Songa, Ki-Duk; Cho, Hyun-Woo; Lee, Hak-Kyo; Cho, Byung Wook Report May 1, 2014 3344
PANOPTICA RAISES $45 MILLION FOR CLINICAL DEVELOPMENT. May 1, 2014 1023
Effect of low-intensity direct current on expression of vascular endothelial growth factor and nitric oxide in diabetic foot ulcers. Mohajeri-Tehrani, Reza; Nasiripoor, Faezeh; Torkaman, Giti; Hedayati, Mehdi; Annabestani, Zohreh; As May 1, 2014 5905
Additional U.S. patent for stem cell technology. Apr 21, 2014 137
Additional U.S. patent for stem cell technology. Apr 21, 2014 137
Germany : Bayer Submits VEGF Trap-Eye (aflibercept solution for injection) for Treatment of Diabetic Macular Edema in Japan. Mar 4, 2014 437
VEGF and bFGF expression and histological characteristics of the bone-tendon junction during acute injury healing. Wang, Lin; Gao, Weiwei; Xiong, Kaiyu; Hu, Kuan; Liu, Xincun; He, Hui Report Mar 1, 2014 5343
The effects of nitrous oxide on vascular endothelial growth factor (VEGF) and its soluble receptor 1 (VEGFR1) in patient undergoing urological surgery. Feb 28, 2014 2938
Novartis receives approval for Lucentis from Japanese regulatory bodies. Feb 25, 2014 122
Novartis receives approval for Lucentis from Japanese regulatory bodies. Feb 25, 2014 118
AVEO Oncology & Astellas Pharma Inc to terminate worldwide collaboration & license agreement for tivozanib and discontinue Phase 2 BATON study for colorectal cancer. Feb 17, 2014 177
AVEO Oncology & Astellas Pharma Inc to terminate worldwide collaboration & license agreement for tivozanib and discontinue Phase 2 BATON study for colorectal cancer. Feb 17, 2014 173
VEGF-A levels in pancreatic fluid can distinguish serous cystic neoplasms, pancreatic cysts - report. Feb 14, 2014 343
PharmaPoint: Microvascular Complications of Diabetes - US Drug Forecast and Market Analysis to 2022. Industry overview Feb 14, 2014 474
Bayer HealthCare and Regeneron report positive two-year results from Phase III VISTA-DME trial of VEGF Trap-Eye. Feb 12, 2014 148
Bayer HealthCare and Regeneron report positive two-year results from Phase III VISTA-DME trial of VEGF Trap-Eye. Feb 12, 2014 144
PharmaPoint: Microvascular Complications of Diabetes - UK Drug Forecast and Market Analysis to 2022. Industry overview Feb 10, 2014 475
VEGF receptor expression decreases during lung development in congenital diaphragmatic hernia induced by nitrofen. Sbragia, L.; Nassr, A.C.C.; Goncalves, F.L.L.; Schmidt, A.F.; Zuliani, C.C.; Garcia, P.V.; Gallindo, Report Feb 1, 2014 5256
Germany : Bayer and Regeneron to Develop New Treatment Option for Wet Age-Related Macular Degeneration. Jan 15, 2014 414
China,United States : Eddingpharm ratifies asset purchase agreement with ACT Biotech. Jan 13, 2014 174
Study shows YKL-40 biomarker may improve detection of mesothelioma. Dec 20, 2013 212
Aerobic exercise boosts memory in young adults. Dec 3, 2013 236
In vivo suppression of hormone-refractory prostate cancer growth by inositol hexaphosphate: induction of insulin-like growth factor binding protein-3 and inhibition of vascular endothelial growth factor. Dec 1, 2013 283
New technique could help block cancer growth. Nov 30, 2013 257
Germany : Data at 48 weeks for Phase 3 MYRROR trial in mCNV demonstrate long-term efficacy of VEGF Trap-Eye. Nov 19, 2013 232
Bayer HealthCare submits marketing authorisation application for VEGF Trap-Eye. Nov 11, 2013 141
Bayer HealthCare submits marketing authorisation application for VEGF Trap-Eye. Nov 11, 2013 137
CURIS & DEBIOPHARM BEGIN PHASE I DOSE FINDING STUDY. Nov 1, 2013 657
BAYER'S STIVARGA (REGORAFENIB) APPROVED IN THE EU. Oct 1, 2013 477
Significance of neuropilin-1 expression in acute myeloid leukemia / Ciddi, Direncli, Oldurucu, Kazanilmis Aplastik Aneminin Klinik Seyrine E Uygulamasinin Katkisi. Sallam, Tarif H.; Shams, Manal A.; El Telbany, Eldin; Mahmoud, Hanan M.; Iskander, Mutea A. Report Sep 1, 2013 4595
Gene expression of VEGF-A and VEGF-C in peripheral blood mononuclear cells of Iranian patients with acute myeloid leukemia / Akut Miyeloid Losemili iranli Hastalarin Periferik Kan Mononukleer Hucrelerinde VEGF-A ve VEGF-C Gen Ekspresyonu. A1iparasti, Mohammad Reza; A1masi, Shohreh; Sanaat, Zohreh; Movasaghpoor, Aliakbar; Khalili-Dizaji, Report Jun 1, 2013 4496
The anti-VEGF dilemma. Withers, Nikki May 17, 2013 1345
Oraya therapy reduces need for anti-VEGF. Withers, Nikki Brief article May 3, 2013 230
Artery formation after heart attack discovered. Apr 30, 2013 253
US study shows VEGF may not be efficient biomarker for advanced prostate cancer. Apr 30, 2013 261
Anaerobic glycosis is the centre of different biochemical disarrays associated with the onset of diabetic retinopathy. Mondal, Lakshmi Kanta; Choudhury, Subhojit; Paine, Suman Kalyan; Sen, Aditi; Bhaduri, Gautam; Bhatta Clinical report Apr 8, 2013 4178
Oraya Therapy[TM] Continues to Show Efficacy for Wet Age-Related Macular Degeneration. Feb 28, 2013 1069
Anti-tumor and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis. Kimura, Yoshiyuki; Sumiyoshi, Maho Report Feb 15, 2013 6287
Germany : Bayer Submits VEGF Trap-Eye (aflibercept) for Treatment of Macular Edema Following Central Retinal Vein Occlusion in Japan. Jan 8, 2013 447
Study to assess the pathophysiological role of VEGF in patients with chronic myeloid leukemia (CML). Meena, L.P.; Prakash, J.; Tandon, R.; Bharti, Anju; Meena, V.K.; Tripathi, K. Report Jan 1, 2013 2536
The effect of intravitreal bevacizumab on apoptosis of rat retina cells/Intravitreal bevacizumabm sican retina hucrelerinde apoptozis uzerine etkileri. Kayikcioglu, Ozcan; Vatansever, Seda; Topcu, Ismet; Aydemir, Isil; Bilecenoglu, Tugce; Kahvecioglu, Report Jan 1, 2013 4315
Germany : Bayer Submits VEGF Trap-Eye (aflibercept) for Treatment of Macular Edema Following Central Retinal Vein Occlusion in EU. Dec 7, 2012 431
Xcovery's Dual VEGF/PDGFR Inhibitor, X-82 Named to 2012 Top Projects to Watch Hot Space List. Nov 30, 2012 1004
Caution over anti-VEGF use. Withers, Nikki Brief article Nov 2, 2012 271
Serum erythropoietin, insulin-like growth factor 1 and vascular endothelial growth factor in ethiopathogenesis of retinopathy of prematurity/Premature retinopatisi etyopatogenezinde serum eritropoetin, insulin benzeri buyume faktoru 1 ve vaskuler endotelyel buyume faktoru. Yenice, Ozlem; Ashour, Ahmed; Cerman, Eren; Firat, Ridvan; Haklar, Goncagul; Sirikci, Onder; Akman, Report Nov 1, 2012 3948
Pharmacological approach for treatment of retinopathy of prematurity /Premature retinopatisinde medikal tedavinin yeri. Akkoyun, Imren Report Nov 1, 2012 6255
Germany : VEGF Trap-Eye (aflibercept ophthalmic injection) Recommended for Approval for the Treatment of Wet Age-Related Macular Degeneration in Europe. Sep 22, 2012 447
Pfizer Receives EU Marketing Authorization for INLYTA[R] (Axitinib). Sep 4, 2012 1865
New economical gene therapy strategy promotes cardiac repair. Jul 8, 2012 381
Levels of serum vascular endothelial growth factor in Type 2 diabetics with retinopathy. Clinical report Jun 30, 2012 2976
Fucoidan extract derived from Undaria pinnatifida inhibits angiogenesis by human umbilical vein endothelial cells. Liu, Fang; Wang, Jia; Chang, Alan K.; Liu, Bing; Yang, Lili; Li, Qiaomei; Wang, Peisheng; Zou, Xiang Report Jun 15, 2012 5457
Exposure to ambient air fine particulate matter prevents VEGF-induced mobilization of endothelial progenitor cells from the bone marrow. Haberzettl, Petra; Lee, Jongmin; Duggineni, Dheeraj; McCracken, James; Bolanowski, Duane; O'Toole, T Clinical report Jun 1, 2012 6348
Prognostic and predictive factors of caninetumours defined with immunohistochemistry's assistance/Fatores prognosticos e preditivos dos tumores caninos definidos com auxilio da imuno-histoquimica. Horta, Rodrigo dos Santos; Costa, Mariana de Padua; Lavalle, Gleidice Eunice; de Araujo, Roberto Bar Jun 1, 2012 4901
Predictors of response to targeted therapy in renal cell carcinoma. Eisengart, Laurie J.; MacVicar, Gary R.; Yang, Ximing J. May 1, 2012 6213
Treatment for AMD halves new cases of blindness in the Netherlands. Brief article May 1, 2012 283
Acceleron's ACE-041 Combined with a VEGF Inhibitor Shows Potent Activity in Preclinical Model of VEGF-Resistant Renal Cell Carcinoma. Apr 3, 2012 661
Dual Inhibition of MET and VEGF Signaling With Cabozantinib Blocks Tumor Invasiveness and Metastasis. Feb 24, 2012 1289
Diabetic macular edema and its treatment modalities/ Diyabetik makula odemi ve tedavi yaklasimlari. Kucumen, Raciha Beril; Yenerel, Nursal Melda Report Jan 1, 2012 5045
Matrix metalloproteinase-9 induces cardiac fibroblast migration, collagen and cytokine secretion: inhibition by salvianolic acid B from Salvia miltiorrhiza. Wang, Yanhui; Xu, Feng; Chen, Jing; Shen, Xu; Deng, Yanping; Xu, Lingling; Yin, Jun; Chen, Hui; Teng Report Dec 15, 2011 4655
Bayer, Regeneron unveil 2 year Phase III results with VEGF Trap-Eye in wet AMD. Clinical report Dec 6, 2011 181
Bayer, Regeneron begin Phase III study of VEGF Trap-Eye in China. Nov 28, 2011 273
Research and Markets: VEGF Inhibition: Therapy-Indicating and Prognostic Biomarkers, 2011. Oct 21, 2011 545
Lpath starts dosing of Isonep in AMD trial. Oct 18, 2011 203
New drug targets to treat debilitating nervous system disease identified. Oct 17, 2011 361
Protective effect of tetramethylpyrazine isolated from Ligusticum chuanxiong on nephropathy in rats with streptozotocin-induced diabetes. Yang, Qi-Hong; Liang, Yong; Xu, Qiang; Zhang, Yi; Xiao, Li; Si, Liang-Yi Report Oct 15, 2011 3453
Serum 25(OH)D and VEGF in diabetes mellitus type 2: gender-specific associations. Panou, Nikol; Georgopoulos, Sotirios; Panou, Marios; Sergentanis, Theodoros N.; Papalampros, Alexand Clinical report Oct 1, 2011 2521
The effects of acute and intermittent hypoxia on the expressions of HIF-1[alpha] and VEGF in the left and right ventricles of the rabbit heart/Akut ve aralikli hipoksinin tavsan kalbinin sol ve sag ventrikullerinde HIF-1[alpha] ve VEGF ekspresyonuna etkileri. Tekin, Demet; Dursun, Ali Dogan; Bastug, Metin; Karaorman, Gokhan; Ficicilar, Hakan Aug 1, 2011 5139
Effect of intravitreal bevacizumab in diabetic macular edema. Shaikh, Fahad Feroze; Arain, Aziz-ur-Rehman Clinical report Jun 30, 2011 3335
Andrographis for lung cancer. Finney-Brown, Tessa Report Jun 22, 2011 596
Spatial memory; visuospatial processes, cognitive performance and developmental effects. Book review Jun 1, 2011 107
Research and Markets: Tivozanib: Newer VEGF Inhibitors Represent A Paradigm Shift In Renal Cell Carcinoma Therapy. May 31, 2011 282
Tanshinone IIA increases recruitment of bone marrow mesenchymal stem cells to infarct region via up-regulating stromal cell-derived factor-1/CXC chemokine receptor 4 axis in a myocardial ischemia model. Tong, Yinghui; Xu, Wei; Han, Hongcan; Chen, Yan; Yang, Jun; Qiao, Hongxiang; Hong, Dongsheng; Wu, Yo Report Apr 15, 2011 5105
Regeneron and Bayer initiate Phase 3 clinical programmes for VEGF Trap-Eye. Apr 8, 2011 246
Parapoxvirus infections of red deer, Italy. Scagliarini, Alessandra; Vaccari, Francesca; Turrini, Filippo; Bianchi, Alessandro; Cordioli, Paolo; Report Apr 1, 2011 1983
Vascular endothelial growth factor (VEGF) regulation of early forebrain neuralepithelium development. Cain, J.T.; Berosik, M.A.; Frisch, S.; Odens, P.W.; Urquhart, S.; Dvorak, S.; Darland, D.C. Apr 1, 2011 536
Evidence-based practice in wound care: toward addressing our knowledge gaps. Bogie, Kath M. Report Mar 1, 2011 1838
Effect of sensory and motor electrical stimulation in vascular endothelial growth factor expression of muscle and skin in full-thickness wound. Asadi, Mohammad Reza; Torkaman, Giti; Hedayati, Mehdi Report Mar 1, 2011 4199
Vascular endothelial growth factor in bronchoalveolar lavage fluid in sulfur mustard exposed lung patients. Karami, Ali; Ghanei, Mostafa; Alaeddini, Farshid; Soltanpour, Mohammad Javad; Pourali, Fatemeh; Yass Report Mar 1, 2011 2312
Astellas and AVEO Pharmaceuticals Enter into Worldwide Agreement to Develop and Commercialize Tivozanib Outside of Asia. Feb 16, 2011 2471
AVEO Pharmaceuticals to present tivozanib clinical data at ASCO 2011. Feb 15, 2011 247
AVEO Pharmaceuticals' Tivozanib Clinical Data Featured at the 2011 ASCO Genitourinary Cancers Symposium. Feb 14, 2011 1474
AVEO Pharmaceuticals Initiates Enrollment in a Phase 2 Exploratory Biomarker Study of Tivozanib. Feb 1, 2011 1276
AVEO Pharmaceuticals' Tivozanib Clinical Data Featured at 2011 ASCO Gastrointestinal Cancers Symposium. Clinical report Jan 21, 2011 1320
Regeneron, Bayer initiate Phase III trial for efficacy, safety of VEGF Trap-Eye. Jan 18, 2011 271
Regeneron announces launch of Phase 3 trial for VEGF Trap-Eye in Asia for CNV. Jan 18, 2011 287
Abnormal vascular endothelial growth factor expression in mesenchymal stem cells from both osteonecrotic and osteoarthritic hips. Mwale, Fackson; Wang, Hongtian; Johnson, Aaron J.; Mont, Michael A.; Antoniou, John Report Jan 1, 2011 3022
Studies advance stroke research. Dec 13, 2010 521
Animal studies advance stroke research. Dec 6, 2010 648
Preclinical studies advance stroke research. Dec 6, 2010 648
Comparison of efficacy between anti-VEGF agents alone and in combination with photodynamic therapy in the treatment of choroidal neovascularization secondary to age-related macular degeneration/Yasa bagli makula dejeneresansina ikincil koroid neovaskularizasyonlarinin tedavisinde anti-VEBF uygulamasi ile fotodinamik tedavi ile anti-VEBF kombinasyonunun etkinliginin karsilastirilmasi. Unlu, Nurten; Acar, Mehmet Akif; Hazirolan, Dicle; Uney, Guner; Acar, Damla E.; Duman, Sunay Report Dec 1, 2010 3648
Anti-angiogenic effect of siphonaxanthin from green alga, Codium fragile. Ganesan, Ponesakki; Matsubara, Kiminori; Ohkubo, Takeshi; Tanaka, Yukihisa; Noda, Kenji; Sugawara, T Dec 1, 2010 4459

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters